301065 Stock Overview
Zhejiang Benli Technology Co., Ltd. engages in the research, development, production, and sale of pharmaceutical, pesticide, and other material intermediates in China and internationally.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 1/6 |
Zhejiang Benli Technology Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥16.52 |
52 Week High | CN¥24.84 |
52 Week Low | CN¥11.81 |
Beta | 0.048 |
1 Month Change | -8.43% |
3 Month Change | -11.23% |
1 Year Change | -17.56% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -68.38% |
Recent News & Updates
Shareholder Returns
301065 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | 5.2% | -1.1% | -0.4% |
1Y | -17.6% | -15.9% | -16.2% |
Return vs Industry: 301065 underperformed the CN Pharmaceuticals industry which returned -15.9% over the past year.
Return vs Market: 301065 underperformed the CN Market which returned -16.2% over the past year.
Price Volatility
301065 volatility | |
---|---|
301065 Average Weekly Movement | 9.9% |
Pharmaceuticals Industry Average Movement | 7.9% |
Market Average Movement | 8.9% |
10% most volatile stocks in CN Market | 12.7% |
10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 301065's share price has been volatile over the past 3 months.
Volatility Over Time: 301065's weekly volatility (10%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2011 | 428 | Zhengjie Wu | www.benlitech.com |
Zhejiang Benli Technology Co., Ltd. engages in the research, development, production, and sale of pharmaceutical, pesticide, and other material intermediates in China and internationally. Its products include N,N-Dimethylamino ethyl acrylate; 2,4-Dichloro-5-fluorobenzoyl chloride; 2-(2,4-Dichloro-5-fluorobenzoyl)-3-cyclopropylamino acrylate ethyl ester; 1-Ethyl-7-(1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid hydrochloride; 2,4-Dichlorofluorobenzene; Methyl 3-Methoxyacrylate; Ethyl 3-ethoxyacrylate; 2,6-Dichlorofluorobenzene; 4-tert-Butylbenzoyl chloride; and 2, 4, 6-Trimethylbenzoyl chloride. The company was founded in 2011 and is based in Linhai, China.
Zhejiang Benli Technology Co., Ltd. Fundamentals Summary
301065 fundamental statistics | |
---|---|
Market cap | CN¥1.75b |
Earnings (TTM) | CN¥55.58m |
Revenue (TTM) | CN¥685.95m |
31.5x
P/E Ratio2.6x
P/S RatioIs 301065 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
301065 income statement (TTM) | |
---|---|
Revenue | CN¥685.95m |
Cost of Revenue | CN¥567.55m |
Gross Profit | CN¥118.41m |
Other Expenses | CN¥62.83m |
Earnings | CN¥55.58m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 24, 2024
Earnings per share (EPS) | 0.52 |
Gross Margin | 17.26% |
Net Profit Margin | 8.10% |
Debt/Equity Ratio | 0% |
How did 301065 perform over the long term?
See historical performance and comparison